SCHEMBL97533

SCHEMBL97533

NS(=O)(=O)CCC[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4805970 0.82
SCHEMBL6285820 0.76
SCHEMBL10457263 0.75 CA2 (0.43)
SCHEMBL10405537 0.75 CA2 (0.39)
SCHEMBL4811467 0.72
SCHEMBL11651534 0.72
SCHEMBL11147913 0.72 CA2 (0.48)
SCHEMBL8069056 0.72 CA2 (0.48)
SCHEMBL30041571 0.72 CA2 (0.48)
SCHEMBL10798852 0.72 CA2 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050272646-A1 Streptogramin antibiotics MCMASTER UNIVERSITY 2005-12-08 US claimed
US-20050130228-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2005-06-16 US claimed
EP-1098659-A4 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS METAPHORE INC (US) 2004-11-24 EP claimed
EP-1476465-A1 METHOD FOR PRODUCING INTERFERON RMF DICTAGENE S.A. (CH) 2004-11-17 EP claimed
WO-2003070764-A1 METHOD FOR PRODUCING INTERFERON RMF DICTAGENE S.A. (CH) 2003-08-28 WO claimed
US-20030138847-A1 Dosing form for a polymer support, use of said dosing form in organic chemical synthesis and method for production of said dosing form H. LUNDBECK A/S (DK) 2003-07-24 US claimed
EP-1268050-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. Lundbeck A/S (DK) 2003-01-02 EP claimed
WO-2001068598-A2 DOSING FORM FOR A POLYMER SUPPORT, USE OF SAID DOSING FORM IN ORGANIC CHEMICAL SYNTHESIS AND METHOD FOR PRODUCTION OF SAID DOSING FORM H. LUNDBECK A/S (DK) 2001-09-20 WO claimed
EP-1098659-A2 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS Metaphore, Inc. (US) 2001-05-16 EP claimed
WO-2000004868-A2 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS METAPHORE, INC. (US) 2000-02-03 WO claimed
WO-2023215032-A2 POTENT ANTI-CANCER CYCLOTIDES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-11-09 WO disclosed
EP-4262879-A1 OLIGOMERIC COMPOUNDS BINDING SPECIFICALLY TO PROTEOGLYCANS Phi Pharma SA (CH) 2023-10-25 EP disclosed
WO-2023133517-A1 SUBDERMAL IMPLANT FOR SUSTAINED DRUG DELIVERY OAK CREST INSTITUTE OF SCIENCE (US) 2023-07-13 WO disclosed
WO-2023056414-A1 STRUCTURAL PROFILING OF NATIVE PROTEINS USING FLUOROSEQUENCING, A SINGLE MOLECULE PROTEIN SEQUENCING TECHNOLOGY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-04-06 WO disclosed
WO-2022129627-A1 OLIGOMERIC COMPOUNDS BINDING SPECIFICALLY TO PROTEOGLYCANS PHI PHARMA SA (CH) 2022-06-23 WO disclosed
WO-2000004868-A2 LIBRARIES OF POLYHYDROXAMATES AND THEIR ANALOGS METAPHORE, INC. (US) 2000-02-03 WO disclosed
WO-1999061583-A2 CARBOHYDRATE-BASED SCAFFOLD COMPOUNDS, COMBINATORIAL LIBRARIES AND METHODS FOR THEIR CONSTRUCTION INCARA PHARMACEUTICALS CORP. (US) 1999-12-02 WO disclosed
WO-1999040435-A1 PROTEIN FOLDING INHIBITORS NETZER WILLIAM J (US) 1999-08-12 WO disclosed
WO-1998053813-A1 CARBOHYDRATE SCAFFOLD COMPOUNDS AND LIBRARIES INCARA PHARMACEUTICALS CORP. (US) 1998-12-03 WO disclosed
WO-1998051697-A2 METHOD FOR PRODUCING POLYMERS HAVING NUCLEO-BASES AS SIDE-GROUPS MORPHOCHEM AG (DE) 1998-11-19 WO disclosed